ADTX Aditxt Corp: Net earnings per share for the last 12 months

Public company logo of Aditxt Inc. (ADTX)

Aditxt is undergoing a painful business model pivot as it strives to become an IT hub for medicine and reduce its debt. The EPS YoY TTM growth trajectory visualizes this process, where 100.20 serves as the base parameter value. Stability is driven by precision immunity tests in the US and optimized express delivery logistics for analysis, ensuring high margins across all operating cycles.

ADTX Aditxt Inc. Earnings per share for the last twelve months (02/11/2024 - 07/11/2026)

Aditxt Corp - analytical breakdowns and key metrics (ADTX)

- market value and analyst target forecast:
Stock Quotes Aditxt|ADTX - Price Target Chart
- company stock capitalization data:
Market Valuation Aditxt Inc.|ADTX - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Aditxt|ADTX - Company Book Value|Capitalization to Book Value Ratio aditxt.com|ADTX - Company Total Assets
- debt burden and liquidity indicators:
Debt to Capital Aditxt|ADTX - Long-Term Debt to Capital|Short-Term Debt to Capital Aditxt|ADTX - Company Aggregate Debts|Debt to Book Value Ratio Aditxt Inc.|ADTX - Company Long-Term Debts|Short-Term Debt Volume Aditxt|Intermediate Liquidity Ratio aditxt.com
- earnings and multiples data:
ADTX - Net Income|Net Profit Forecast Aditxt|ADTX - Price to Earnings Ratio|Market Cap to Future Earnings Ratio Aditxt|ADTX - PEG Multiple|EV/EBITDA Multiple Aditxt Inc.|ADTX - Operating profit EBITDA|Earnings per share for the last 12 months Aditxt|ADTX - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months aditxt.com|ADTX - Net earnings per share growth this year|Projected earnings per share growth rate for next year Aditxt
Fundamental company valuation:Aditxt, Inc., ADTX
Core merchandise of Aditxt Corp

For Aditxt (ADTX), a leader in the immune monitoring niche, this indicator reflects the monetization efficiency of the AditxtScore platform. The metric measures the percentage change in net income per share over the last 12 months. Analysis of the EPS TTM annual trend chart reveals hidden rates of business deceleration. Inelastic demand for transplantation tests provides the company with pricing power. Stable profit growth confirms the fundamental resilience of the business model.

Competitor analysis for Aditxt

argenx.com (ARGX) - Net earnings per share for the last 12 months|BioNTech (BNTX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Abivax Corp|Net earnings per share for the last 12 months ADMA|Net earnings per share (EPS TTM) Protagonist Corp|Earnings per share for the last twelve months Immunovant, Inc. (IMVT)|kiniksa.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) GRFS (Grifols)|Adaptive Biotech (ADPT) - Net earnings per one share for the last twelve months|Celldex - Net earnings per share (EPS TTM)|AUPH - Net earnings per share (EPS TTM)|BCRX: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months VERA|DNTH (Dianthus Therapeutics, Inc.) - Net earnings per share (EPS TTM)|Pharvaris NV (PHVS) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months ABCL (AbCellera Corp)|Earnings per share for the last four quarters TRML|Precigen, Inc. - Net earnings per share for the last 12 months|PHAR: Earnings per share for the last 12 months|NKTR: Net earnings per share for the last 12 months|Upstream Bio, Inc. - Earnings per share for the last four quarters|ZBIO: Net earnings per share (EPS TTM)|Immunome Bio (IMNM) - Net earnings per share (EPS TTM)|GOSS (Gossamer Bio, Inc.) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months KALV (kalvista.com)|Net earnings per share for the last 12 months SEPN (Septerna)|Earnings per share for the last four quarters PVLA|Savara Corp - Net earnings per share for the last 12 months|RIGL: Earnings per share for the last 12 months|ANAB - Earnings per share for the last twelve months|Earnings per one share for the last 12 months ATXS|ENGN: Net earnings per share (EPS TTM)|rapt.com - Earnings per share for the trailing year|JBIO (Aerovate Therapeutics, Inc.) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Aclaris Therapeutics, Inc|Earnings per share for the last twelve months Kyverna Therapeutics (KYTX)|TLSA (tizianalifesciences.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Cabaletta Bio CABA|VTYX - Net earnings per share for the last 12 months|Theratechnologies Inc - Net earnings per share (EPS TTM)|AVTX - Net earnings per share (EPS TTM)|ELDN (Eledon Pharmaceuticals) - Net earnings per share for the last 12 months|agenusbio.com - Earnings per share for the trailing year|CLYM (Climb Bio) - Net earnings per share (EPS TTM)|zurabio.com (ZURA) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months aTyr (ATYR)|Net earnings per share for the last 12 months adagene.com ADAG|Earnings per share for the last twelve months Ikena Oncology IMA|STTK - Net earnings per share for the last 12 months|EQ: Net earnings per share for the last 12 months|CNTB - Net earnings per share (EPS TTM)|immunic-therapeutics.com (IMUX) - Earnings per share for the last twelve months|Earnings per share for the last 12 months ATRA|IFRX (InflaRx NV) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months x4pharma.com XFOR|Net earnings per share (EPS TTM) ACET|Net earnings per share (EPS TTM) celularity.com (CELU)|Net earnings per share (EPS TTM) INMB (INmune Bio Corp)|BRNS: Earnings per share for the last 12 months|Kezar Life Sciences - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters sabbiotherapeutics.com SABS|AKTX (Akari Therapeutics Plc) - Net earnings per share for the last 12 months|ENLV: Earnings per share for the last four quarters|Net earnings per share for the last 12 months QTTB|Earnings per share for the last 12 months GOVX (GeoVax Corp)|Net earnings per share for the last 12 months EDSA (Edesa Biotech, Inc.)|Earnings per share for the last four quarters IBIO|Net earnings per share (EPS TTM) CARM (Carisma Therapeutics Inc.)|Net earnings per share (EPS TTM) XTL Biopharmaceuticals Ltd XTLB|Bolt Bio - Net earnings per share (EPS TTM)|HCWB (HCW Biologics Inc.) - Earnings per share for the last 12 months|APVO (aptevotherapeutics.com) - Net earnings per share for the last 12 months|AIM: Earnings per share for the last four quarters|Net earnings per share for the last 12 months GRI|Earnings per share for the last 12 months XRTX (XORTX Therapeutics Inc)|Earnings per share for the last twelve months ReShape Lifesciences (HIND)|REVB: Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) INDP (Indaptus Therapeutics)|Earnings per share for the trailing year SCNI|CalciMedica Corp - Net earnings per share (EPS TTM)|AFMD - Net earnings per share (EPS TTM)|allakos.com (ALLK) - Earnings per share for the last twelve months|HOOKIPA Pharma - Earnings per share for the trailing year|Earnings per share for the last twelve months IGM Biosciences Inc.|Net earnings per share for the last 12 months iteostherapeutics.com (ITOS)|Net earnings per share (EPS TTM) OCEA|Net earnings per share (EPS TTM) TC BioPharm (Holdings) Plc (TCBP)|Third Harmonic Bio, Inc - Net earnings per share for the last 12 months